QQ客服 官方微博 反馈留言

	Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway
	Li, Tianqi; Xiong, Yudi; Wang, Qingqing; Chen, Fengxia; Zeng, Yangyang; Yu, Xiaoyan; Wang, Yuan; Zhou, Fuxiang; Zhou, Yunfeng
刊名	ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
	2019
卷号	47期号:1
关键词	Triple-negative breast cancer ribociclib (LEE011) proliferation cell cycle apoptosis
ISSN号	2169-1401
DOI	10.1080/21691401.2019.1670670
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4233770
专题	武汉大学
推荐引用方式 GB/T 7714	Li, Tianqi,Xiong, Yudi,Wang, Qingqing,et al. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway[J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY,2019,47(1).
APA	Li, Tianqi.,Xiong, Yudi.,Wang, Qingqing.,Chen, Fengxia.,Zeng, Yangyang.,...&Zhou, Yunfeng.(2019).Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY,47(1).
MLA	Li, Tianqi,et al."Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway".ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 47.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。